Once we demonstrated that NRF2 has a positive correlation with ABCC1 expression in vitro (Figs. 2A, B, 4F, and 5A, D), we next investigated whether the expression of those genes would present a similar pattern in glioma patients. This evidence concerns the gene NFE2L2 and central nervous system cancer.